🔎 Trials Near Me

Pradžia › Virškinimo trakto vėžys › Merilendas

Virškinimo trakto vėžys klinikiniai tyrimai Merilendas

14 tyrimai dėl Virškinimo trakto vėžys ieško dalyvių vietose Merilendas.

Miestai Merilendas

Oficialus tyrimo tekstas (anglų kalba)

Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosis From Peritoneal Mesothelioma or Atypical Mesothelial Proliferation or From Ovarian, Colorectal, or Appendiceal Histologies

  • National Institutes of Health Clinical Center, Bethesda
Renkami dalyviai1 fazė
Amžius nuo 18 iki 120 · Visoms lytims · Atnaujinta 2026-10-02 · NCT04847063

Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays

  • Christiana Care - Union Hospital, Elkton
Renkami dalyviaiLaukiami sveiki savanoriai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-10-02 · NCT07283939

Surgical Thromboprophylaxis Practices in Oncology Patients Within the NCORP Network, STOP-VTE Study

  • Christiana Care - Union Hospital, Elkton
Renkami dalyviaiStebimasis tyrimasLaukiami sveiki savanoriai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-10-02 · NCT07215624

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

  • Greater Baltimore Medical Center, Baltimore
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-28 · NCT07222800

A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy

  • GSK Investigational Site, Baltimore
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-25 · NCT07218926

Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors

  • The Sidney Kimmel Comprehensive Cancer Center at John Hopkins, Baltimore
Renkami dalyviai1/2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-22 · NCT06445062

Acquisition of Blood and Tumor Tissue Samples From Patients With Gastrointestinal Cancer

  • National Institutes of Health Clinical Center, Bethesda
Renkami dalyviaiStebimasis tyrimas
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-14 · NCT01313442

Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients

  • National Institutes of Health Clinical Center, Bethesda
Renkami dalyviai1/2 fazė
Amžius nuo 18 iki 72 · Visoms lytims · Atnaujinta 2026-08-24 · NCT03190941

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

  • National Institutes of Health, Bethesda
Renkami dalyviai1/2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-11 · NCT05592626

Immunobiology Blood and Tissue Collection of Upper Aerodigestive Malignancies

  • Johns Hopkins University, Baltimore
Renkami dalyviaiStebimasis tyrimas
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-06 · NCT05995821

Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors

  • Johns Hopkins University, Baltimore
Renkami dalyviai1 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-06-03 · NCT06040541

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

  • Johns Hopkins University, Baltimore
Renkami dalyviai1/2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-05-15 · NCT05379985

A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors

  • Johns Hopkins University, Baltimore
Renkami dalyviai1/2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-04-22 · NCT07020221

REmote Symptom COllection to improVE postopeRative Care

  • MedStar Health, Baltimore
Renkami dalyviai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2025-04-03 · NCT06190730

Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.